The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Transgenic sickle mice have vascular inflammation
Open accessAbstract
Inflammation may play an essential role in vaso-occlusion in sickle cell disease. Sickle patients have high white counts and elevated levels of serum C-reactive protein (CRP), cytokines, and adhesion molecules. In addition, circulating endothelial cells, leukocytes, and platelets are activated. We examined 4 transgenic mouse models expressing human α- and sickle β-globin genes to determine if they mimic the inflammatory response seen in patients. These mouse models are designated NY-S, Berk-SAntilles, NY-S/SAntilles (NY-S × Berk-SAntilles), and Berk-S. The mean white counts were elevated 1.4- to 2.1-fold (P ≤ .01) in the Berk-SAntilles, NY-S/SAntilles, and Berk-S mice, but not in the NY-S mice compared with controls. Serum amyloid P-component (SAP), an acute-phase response protein with 60% to 70% sequence homology to CRP, was elevated 8.5- to 12.1-fold (P ≤ .001) in transgenic sickle mice. Similarly, serum interleukin-6 (IL-6) was elevated 1.6- to 1.9-fold (P ≤ .05). Western blots, confirming immunohistochemical staining, showed vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), and platelet-endothelial cell adhesion molecule (PECAM) were up-regulated 3- to 5-fold (P ≤ .05) in the lungs of sickle mice. Ribonuclease protection assays (RPAs) demonstrated VCAM mRNA also was elevated in sickle mice 1.2- to 1.4-fold (P ≤ .01). Nuclear factor κB (NF-κB), a transcription factor critical for the inflammatory response, was elevated 1.9-fold (P ≤ .006) in NY-S sickle mouse lungs. We conclude that transgenic sickle mice are good models to study vascular inflammation and the potential benefit of anti-inflammatory therapies to prevent vaso-occlusion in sickle cell disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*
WUN, T., CORDOBA, M., RANGASWAMI, A., CHEUNG, A. W., & PAGLIERONI, T. (2002) · Clinical and Laboratory Haematology · doi:10.1046/j.1365-2257.2002.t01-1-00433.x · Cited by 130
Research works printed but not linked: 72
- Embury, 1994, Pathogenesis of vasoocclusion., Sickle Cell Disease: Basic Principles and Clinical Practice., 21, 311
- Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice., J Clin Invest., 106, 411, 10.1172/JCI9225 · DOI · Paper page
- Turhan, 2002, Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm., Proc Natl Acad Sci U S A., 99, 3047, 10.1073/pnas.052522799 · DOI · Paper page
- Buchanan, 1983, Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia., J Pediatr., 103, 921, 10.1016/S0022-3476(83)80716-1 · DOI
- Awogu, 2000, Leucocyte counts in children with sickle cell anaemia usefulness of stable state values during infections., West Afr J Med., 19, 55
- Castro, 1994, The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease., Blood., 84, 643, 10.1182/blood.V84.2.643.643 · DOI · Paper page
- Hedo, 1993, Acute phase reactants and severity of homozygous sickle cell disease., J Intern Med., 233, 467, 10.1111/j.1365-2796.1993.tb01000.x · doi:10.1111/j.1365-2796.1993.tb01000.x
- Singhal, 1993, Is there an acute-phase response in steady-state sickle cell disease?, Lancet., 341, 651, 10.1016/0140-6736(93)90418-G · doi:10.1016/0140-6736(93)90418-g
- Stuart, 1994, Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease., J Clin Pathol., 47, 166, 10.1136/jcp.47.2.166 · DOI
- Belcher, 2000, Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion., Blood., 96, 2451, 10.1182/blood.V96.7.2451 · DOI · Paper page
- Francis, 1992, Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease., J Natl Med Assoc., 84, 611
- Malave, 1993, Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease., Acta Haematol., 90, 172, 10.1159/000204452 · DOI
- Croizat, 1994, Circulating cytokines in sickle cell patients during steady state., Br J Haematol., 87, 592, 10.1111/j.1365-2141.1994.tb08318.x · DOI
- Kuvibidila, 1997, Tumor necrosis factor alpha in children with sickle cell disease in stable condition., J Natl Med Assoc., 89, 609
- Hofstra, 1996, Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst., Blood., 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI
- Fadlon, 1998, Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64., Blood., 91, 266, 10.1182/blood.V91.1.266 · DOI · Paper page
- Lard, 1999, Neutrophil activation in sickle cell disease., J Leukoc Biol., 66, 411, 10.1002/jlb.66.3.411 · DOI · Paper page
- Kenny, 1980, Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism., J Clin Pathol., 33, 622, 10.1136/jcp.33.7.622 · DOI · Paper page
- Westwick, 1983, Platelet activation during steady state sickle cell disease., J Med., 14, 17
- Beurling-Harbury, 1989, Platelet activation during pain crisis in sickle cell anemia patients., Am J Hematol., 31, 237, 10.1002/ajh.2830310404 · DOI
- Papadimitriou, 1993, Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis., Acta Haematol., 89, 180, 10.1159/000204519 · doi:10.1159/000204519
- Wun, 1997, Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia., J Lab Clin Med., 129, 507, 10.1016/S0022-2143(97)90005-6 · DOI · Paper page
- Wun, 1999, Platelet-erythrocyte adhesion in sickle cell disease., J Investig Med., 47, 121
- Inwald, 2000, Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia., Br J Haematol., 111, 474, 10.1046/j.1365-2141.2000.02353.x · DOI
- Solovey, 1997, Circulating activated endothelial cells in sickle cell anemia., N Engl J Med., 337, 1584, 10.1056/NEJM199711273372203 · DOI · Paper page
- Solovey, 1998, Tissue factor expression by endothelial cells in sickle cell anemia., J Clin Invest., 101, 1899, 10.1172/JCI1932 · DOI · Paper page
- Duits, 1996, Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis., Clin Immunol Immunopathol., 81, 96, 10.1006/clin.1996.0163 · DOI
- Saleh, 1998, Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy., Acta Haematol., 100, 26, 10.1159/000040859 · DOI
- Saleh, 1999, Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy., Acta Haematol., 102, 31, 10.1159/000040964 · DOI
- Stuart, 1999, Sickle cell acute chest syndrome: pathogenesis and rationale for treatment., Blood., 94, 1555, 10.1182/blood.V94.5.1555 · DOI · Paper page
- Fabry, 1992, High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia., Proc Natl Acad Sci U S A., 89, 12155, 10.1073/pnas.89.24.12155 · DOI
- Rubin, 1991, Hypoxia-induced in vivo sickling of transgenic mouse red cells., J Clin Invest., 87, 639, 10.1172/JCI115041 · DOI
- Fabry, 1995, A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity., Blood., 86, 2419, 10.1182/blood.V86.6.2419.bloodjournal8662419 · DOI
- Kaul, 1995, In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse., J Clin Invest., 96, 2845, 10.1172/JCI118355 · DOI
- Embury, 1999, In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse., J Clin Invest., 103, 915, 10.1172/JCI5977 · DOI
- Osarogiagbon, 2000, Reperfusion injury pathophysiology in sickle transgenic mice., Blood., 96, 314, 10.1182/blood.V96.1.314 · DOI · Paper page
- Skow, 1983, A mouse model for beta-thalassemia., Cell., 34, 1043, 10.1016/0092-8674(83)90562-7 · DOI · Paper page
- Fabry, 1992, High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences., Proc Natl Acad Sci U S A., 89, 12150, 10.1073/pnas.89.24.12150 · DOI
- Burlingame, 1996, The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice., J Immunol., 156, 4783, 10.4049/jimmunol.156.12.4783 · DOI
- Deryckere, 1994, A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues., BioTechniques., 16, 405
- Brown, 1989, Protein measurement using bicinchoninic acid: elimination of interfering substances., Anal Biochem., 180, 136, 10.1016/0003-2697(89)90101-2 · DOI · Paper page
- Pepys, 1977, Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein., Lancet., 1, 1029, 10.1016/S0140-6736(77)91260-0 · DOI · Paper page
- Osmand, 1977, Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins)., Proc Natl Acad Sci U S A., 74, 739, 10.1073/pnas.74.2.739 · DOI · Paper page
- Siebenlist, 1994, Structure, regulation and function of NF-kappa B., Annu Rev Cell Biol., 10, 405, 10.1146/annurev.cb.10.110194.002201 · DOI · Paper page
- Le, 1984, In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1., J Leukoc Biol., 35, 587, 10.1002/jlb.35.6.587 · doi:10.1002/jlb.35.6.587
- Hebbel, 1981, Modulation of erythrocyte-endothelial interactions and the vasooclusive severity of sickling disorders., Blood., 58, 947, 10.1182/blood.V58.5.947.bloodjournal585947 · doi:10.1182/blood.v58.5.947.bloodjournal585947
- Hebbel, 1985, The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes., Clin Haematol., 14, 141, 10.1016/S0308-2261(21)00466-5 · DOI
- Kaul, 1989, Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications., Proc Natl Acad Sci U S A., 86, 3356, 10.1073/pnas.86.9.3356 · DOI · Paper page
- Francis, 1991, Vascular occlusion in sickle cell disease: current concepts and unanswered questions., Blood., 77, 1405, 10.1182/blood.V77.7.1405.1405 · DOI · Paper page
- Hebbel, 1994, Sickle cell adherence., 217
- Hebbel, 1997, The endothelial biology of sickle cell disease., J Lab Clin Med., 129, 288, 10.1016/S0022-2143(97)90176-1 · DOI
- Bernini, 1998, Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease., Blood., 92, 3082, 10.1182/blood.V92.9.3082 · DOI · Paper page
- Mahoney, 1983, Monocyte functions in sickle cell disorders., Am J Pediatr Hematol Oncol., 5, 409, 10.1097/00043426-198324000-00016 · DOI
- Boghossian, 1991, Abnormal neutrophil adhesion in sickle cell anaemia and crisis: relationship to blood rheology., Br J Haematol., 78, 437, 10.1111/j.1365-2141.1991.tb04461.x · DOI
- Mohamed, 1993, Increased in vivo activation of neutrophils and complement in sickle cell disease., Am J Trop Med Hyg., 49, 799, 10.4269/ajtmh.1993.49.799 · DOI
- Mollapour, 1998, Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease., Blood., 91, 3423, 10.1182/blood.V91.9.3423 · DOI
- Abboud, 1998, Granulocytosis causing sickle-cell crisis., Lancet., 351, 959, 10.1016/S0140-6736(05)60614-9 · DOI
- Adler, 2001, Fatal sickle cell crisis after granulocyte colony-stimulating factor administration., Blood., 97, 3313, 10.1182/blood.V97.10.3313 · DOI · Paper page
- Grigg, 2001, Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia., Blood., 97, 3998, 10.1182/blood.V97.12.3998 · DOI
- Charache, 1992, Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia., Blood., 79, 2555, 10.1182/blood.V79.10.2555.2555 · DOI · Paper page
- Platt, 1995, Sickle cell paths converge on hydroxyurea., Nat Med., 1, 307, 10.1038/nm0495-307 · DOI
- Charache, 1996, Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia., Medicine (Baltimore, MD)., 75, 300, 10.1097/00005792-199611000-00002 · DOI · Paper page
- Howard, 1997, Hydroxyurea in the treatment of sickle-cell anemia., Ann Pharmacother., 31, 1393
- Hebbel, 1982, Spontaneous oxygen radical generation by sickle erythrocytes., J Clin Invest., 70, 1253, 10.1172/JCI110724 · DOI · Paper page
- Shi, 1999, The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB., Mol Cell Biochem., 194, 63, 10.1023/A:1006904904514 · DOI
- McFaul, 2000, Hemoglobin stimulates the release of proinflammatory cytokines from leukocytes in whole blood., J Lab Clin Med., 135, 263, 10.1067/mlc.2000.105180 · DOI
- Hammerman, 1997, Endothelin-1 production during the acute chest syndrome in sickle cell disease., Am J Respir Crit Care Med., 156, 280, 10.1164/ajrccm.156.1.9611085 · DOI
- Werdehoff, 1998, Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy., Am J Hematol., 58, 195, 10.1002/(SICI)1096-8652(199807)58:3<195::AID-AJH6>3.0.CO;2-M · doi:10.1002/(sici)1096-8652(199807)58:3<195::aid-ajh6>3.0.co;2-m
- Graido-Gonzalez, 1998, Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis., Blood., 92, 2551, 10.1182/blood.V92.7.2551 · DOI · Paper page
- Faller, 1999, Endothelial cell responses to hypoxic stress., Clin Exp Pharmacol Physiol., 26, 74, 10.1046/j.1440-1681.1999.02992.x · DOI · Paper page
- Phelan, 1995, Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture., J Clin Invest., 96, 1145, 10.1172/JCI118102 · DOI
- Zimmerman, 1994, Mechanisms of reperfusion injury., Am J Med Sci., 307, 284, 10.1097/00000441-199404000-00009 · DOI · Paper page
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Self-citationBelcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695
Self-citation
Metadata
- Authors
- Belcher, J. D., Bryant, C. J., Nguyen, J., Bowlin, P. R., Kielbik, M. C., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2003-05-15
- Volume
- 101
- Issue
- 10
- Pages
- 3953-3959
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1968642156
- Cited by
- 242
- References
- 6
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transgenic sickle mice have vascular inflammation. https://app.cochat.ai/papers/10.1182/blood-2002-10-3313
- The paper
- Belcher, J. D., Bryant, C. J., Nguyen, J., Bowlin, P. R., Kielbik, M. C., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2003). Transgenic sickle mice have vascular inflammation. Blood. https://doi.org/10.1182/blood-2002-10-3313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.